MiMedx Group, Inc. (MDXG)
4.59
-0.05
(-1.08%)
USD |
NASDAQ |
Oct 02, 16:00
4.59
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Gross Profit Margin (Quarterly) : 68.50% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.50% |
| March 31, 2026 | 70.05% |
| December 31, 2025 | 83.76% |
| September 30, 2025 | 83.44% |
| June 30, 2025 | 80.95% |
| March 31, 2025 | 81.12% |
| December 31, 2024 | 81.59% |
| September 30, 2024 | 81.54% |
| June 30, 2024 | 82.75% |
| March 31, 2024 | 84.45% |
| December 31, 2023 | 83.84% |
| September 30, 2023 | 81.67% |
| June 30, 2023 | 83.05% |
| March 31, 2023 | 82.41% |
| December 31, 2022 | 80.44% |
| September 30, 2022 | 81.74% |
| June 30, 2022 | 82.06% |
| March 31, 2022 | 82.84% |
| December 31, 2021 | 83.79% |
| September 30, 2021 | 83.64% |
| June 30, 2021 | 80.97% |
| March 31, 2021 | 83.52% |
| December 31, 2020 | 83.85% |
| September 30, 2020 | 83.57% |
| June 30, 2020 | 84.21% |
| Date | Value |
|---|---|
| March 31, 2020 | 83.32% |
| December 31, 2019 | 80.66% |
| September 30, 2019 | 82.79% |
| June 30, 2019 | 82.38% |
| March 31, 2019 | 85.55% |
| December 31, 2018 | 86.36% |
| September 30, 2018 | 89.62% |
| June 30, 2018 | 88.67% |
| March 31, 2018 | 87.13% |
| December 31, 2017 | 89.16% |
| September 30, 2017 | 88.16% |
| June 30, 2017 | 88.04% |
| March 31, 2017 | 87.23% |
| December 31, 2016 | 86.68% |
| September 30, 2016 | 86.61% |
| June 30, 2016 | 86.33% |
| March 31, 2016 | 83.59% |
| December 31, 2015 | 89.93% |
| September 30, 2015 | 89.36% |
| June 30, 2015 | 88.35% |
| March 31, 2015 | 86.80% |
| December 31, 2014 | 90.32% |
| September 30, 2014 | 89.32% |
| June 30, 2014 | 88.38% |
| March 31, 2014 | 83.60% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Agenus, Inc. | 98.50% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.66% |
| Return on Assets | 2.02% |
| Return on Invested Capital | 2.47% |
| Profit Margin (Quarterly) | -23.06% |
| Operating Margin (Quarterly) | -28.69% |
| Return on Net Operating Assets | 4.56% |